Novec 7500 engineered fluid
Novec™ 7500 engineered fluid is a specialty chemical product designed for use in various laboratory applications. It is a clear, colorless liquid with unique properties that make it suitable for specific purposes. The core function of Novec™ 7500 is to serve as a solvent, heat transfer fluid, or other specialized application in controlled laboratory environments.
Lab products found in correlation
10 protocols using novec 7500 engineered fluid
Droplet Merging on Microfluidic Chips
Microfluidic Compartmentalization for Cell Encapsulation
Example 2
The cells may be compartmentalised as follows. Preferably, a low viscosity hydrofluoroether (such as 3M™ Novec™ 7500 engineered fluid (HFE7500) that offers high gas transport and avoids swelling of PDMS devices, was used as the continuous phase. A fluorosurfactant (in this case, 2% (v/v) Krytox®-PEG600 based fluorosurfactant) was added to the continuous phase to facilitate droplet breakup, stabilize emulsions and to avoid coalescence. Two dispersed phases were used: (1) 0.6% (wt) alginate containing 84 mM Ca2+/84 mM EDTA/40 mM MOPS at pH 6.7 and (2) 0.6% (wt) alginate containing 84 mM Zn2+/100 mM EDDA/40 mM MOPS at pH 6.7. The two aqueous phases meet in a co-flow region in the microfluidic channels prior to droplet break-up.
The flow rates were set to 200 μL/hr for the continuous phase and 50 μL/hr for both aqueous phases by controlled injection using plastic syringes mounted on syringe pumps from Harvard Apparatus (PHD ULTRA). The syringes used for the dispersed phases contained magnets and were continuously stirred to avoid sedimentation of cells. Cells may be present in both aqueous phases to increase the encapsulation efficiency.
Microfluidic Fabrication of GelMA Microgels
Microfluidic Device Fabrication Protocol
Microfluidic Cell Encapsulation Protocol
Microfluidic Yeast Cell Encapsulation
Microfluidic Droplet Merging Protocol
PDMS-Glass Microfluidic Device Fabrication
Microfluidic Alginate Bead Encapsulation
Example 2
The cells may be compartmentalised as follows. Preferably, a low viscosity hydrofluoroether (such as 3M™ Novec™ 7500 engineered fluid (HFE7500) that offers high gas transport and avoids swelling of PDMS devices, was used as the continuous phase. A fluorosurfactant (in this case, 2% (v/v) Krytox®-PEG600 based fluorosurfactant) was added to the continuous phase to facilitate droplet breakup, stabilize emulsions and to avoid coalescence. Two dispersed phases were used: (1) 0.6% (wt) alginate containing 84 mM Ca2+/84 mM EDTA/40 mM MOPS at pH 6.7 and (2) 0.6% (wt) alginate containing 84 mM Zn2+/100 mM EDDA/40 mM MOPS at pH 6.7. The two aqueous phases meet in a co-flow region in the microfluidic channels prior to droplet break-up.
The flow rates were set to 200 μL/hr for the continuous phase and 50 μL/hr for both aqueous phases by controlled injection using plastic syringes mounted on syringe pumps from Harvard Apparatus (PHD ULTRA). The syringes used for the dispersed phases contained magnets and were continuously stirred to avoid sedimentation of cells. Cells may be present in both aqueous phases to increase the encapsulation efficiency.
Microfluidic Chip Fabrication and Preparation
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!